Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Human immunodeficiency virus (HIV)60.8M32.72%
Sample Management Solutions51.05M27.47%
Coronavirus disease 2019 (COVID-19)45.17M24.31%
Hepatitis C virus (HCV)14.02M7.55%
Risk assessment testing8.35M4.50%
Other product and service revenues3.51M1.89%
Molecular Services1.71M0.92%
Non-product and services revenues1.22M0.65%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States139.16M74.89%
Africa32.75M17.62%
Europe8.42M4.53%
Other regions5.5M2.96%